Intestinal Health Clinical Trial
Official title:
Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults
This study aims to establish the safety of a 15 g/day dose of pure prebiotics ß(1-4) galacto-oligosaccharides (GOS) and GOS enriched with N-Acetyl-D-lactosamine, a building block of gut glycoproteins and human milk oligosaccharides (LAcNac, humanized GOS, hGOS) in healthy adult individuals. The safety and tolerability of the dose and the biological signature of GOS and hGOS in healthy adults will be established through a pilot clinical trial to assess GOS and hGOS effects vs placebo on (i) gastrointestinal adverse effects as measured by the Gastrointestinal Symptom and Severity Checklist (GSSC), (ii) increased abundance of beneficial gut bacteria and restoration of the gut microbiome saccharolytic potential, (iii) modulation of biomarkers of inflammation and (iv) evaluation of intestinal barrier function.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03313440 -
Fiber Intake & Fecal Bulk Enhanced Response
|
N/A | |
| Completed |
NCT01241201 -
Intestinal Barrier Function and Probiotics.
|
N/A | |
| Completed |
NCT04570137 -
Fiber Fermentation Study
|
N/A | |
| Completed |
NCT04375475 -
Evaluation of the Effect of Changyou Probiotic Flavored Yogurt on Intestinal Health
|
N/A | |
| Enrolling by invitation |
NCT04526678 -
Oslo Footballplayers Iron Supplementation and Training (FIT) Study
|
N/A |